Stockreport

Royalty Pharma and J&J partner to develop autoimmune treatment [Yahoo! Finance]

Royalty Pharma plc - Class A Ordinary Shares  (RPRX) 
US:NASDAQ Investor Relations: ir.reprosrx.com/investor-relations
PDF Shares of Royalty Pharma were up 1.4% in premarket ?trading, while ?those of J&J rose nearly 0.7%. * The co-funding agreement, covering ?2026 and 2027, willsupport th [Read more]